Alirocumab (anti-PCSK9)

Purity: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated Synonym(s): Recombinant Alirocumab Antibody; REGN 727; SAR 236553; Alirocumab (anti-PCSK9); Anti-PCSK9 Reference Antibody (alirocumab); Convertase subtilisin/kexin type 9 preproprotein antibody; FH3 antibody; HCHOLA3 antibody; Hypercholesterolemia autosomal dominant 3 antibody; LDLCQ1 antibody; NARC 1 antibody; NARC-1 antibody; NARC1 antibody; Neural apoptosis regulated convertase 1 antibody; Neural apoptosis-regulated convertase 1 antibody; PC 9 antibody; PC9 antibody; PCSK 9 antibody; PCSK9 antibody; PCSK9_HUMAN antibody; Proprotein convertase 9 antibody; Proprotein convertase PC9 antibody; Proprotein convertase subtilisin/kexin type 9 antibody; PSEC0052 antibody; Subtilisin/kexin like protease PC9 antibody; Subtilisin/kexin-like protease PC9 antibody; EC 3.4.21; EC 3.4.21.111; FH3; FH3neural apoptosis regulated convertase 1; FHCL3; HCHOLA3; Hypercholesterolemia, autosomal dominant 3; LDLCQ1; NARC1; NARC-1; NARC-1convertase subtilisin/kexin type 9 preproprotein; NARC1EC 3.4.21.-; Neural apoptosis-regulated convertase 1; PC9; PCSK9; Proprotein Convertase 9; Proprotein convertase subtilisin/kexin type 9; Subtilisin/kexin-like protease PC9 Formula: C6472H9996N1736O2032S42 Molecular Weight: 145979.72 CAS Number: 1245916-14-6 PubChem CID: 88214187

Properties

Shelf life: 730 days

Solubility:

Sensitivity:

Boiling point:

Melting point:

InChl: InChI=1S/C3H9O6P.2Na/c4-1-3(5)2-9-10(6, 7)8; ; /h3-5H, 1-2H2, (H2, 6, 7, 8); ;

Safety Information

Pictograms:

Signal Word:

Hazard Statements:

Precautionary Statements:

WGK:

Storage: Store at -80°C; Avoid repeated freezing and thawing

Personal Protective Equipment: